ASK the Experts 

1. Educational materials and virtual training, tailored to provider, to support monitoring, including:

  • ASK the Experts Remote Monitoring Provider Quick Guide, including explanation of available tools and methods of monitoring for development of dysglycemia and diabetes

  • Finger poke kits that include SST for ab testing and EDTA for A1C & BG, including finger poke blood collection video

  • Continuous Glucose Monitors (CGM) placement video

  • Home Oral Glucose Tolerance Tests (OGTT)

  • Phone calls/texts/emails/zoom sessions to support use of home glucose testing, review ofT1D symptoms, answer questions about blood glucose levels and T1D risk, CGM placement training, provide urine ketone strips and glucometer supplies as needed (new glucometers available with remote sharing of blood glucose)

  • Electronic versions of educational materials including the Blood Glucose Chart, ASK T1D and celiac disease (CD) educational handouts, and information on how to interpret lab results for islet autoantibodies and tissue transglutaminase (tTGA) in terms of the individual risk of progression to clinical diabetes and recommend appropriate tests for confirmation of positive screening results

  • Access to ASK clinical psychologist with specialized training in working with children and families with medical illnesses will provide support to patients and families as needed

  • Ensuring EPIC note about T1D risk is in medical record for those that have agreed

2. Partnering with local lab or ASK to repeat autoantibody tests, HbA1c and blood glucose as needed.

3. Partnering with local TrialNet site, as appropriate: TrialNet can screen all subjects found to be autoantibody positive outside of TrialNet between the ages of 2.5-45 years, including general population and no family history. TrialNet has an online screening form/consent with options for subjects to either do a home collection, go to a local lab (Quest/LabCorp) or go to a TrialNet center or affiliate.

4. Partnering with families to support effective monitoring (including use of glucometer, CGM, and home OGTTs free of charge).

5. Serving as liaison between family and provider to support the child’s safe progression to T1D.

6. Provide current information regarding access to screening for islet autoantibodies within the U.S.

 NEXT STEPS:  If you have questions about screening for type 1 diabetes, interpreting screening results or determining a follow-up plan after receiving results, please e-mail us at or call us at 303-724-1275 and a member of ASK the Experts will reach out to you.